Mintz Levin’s William C. Hicks to Moderate Panel at 2013 BIO CEO and Investor Conference

BIO CEO & Investor Conference 2013

NEW YORK--()--William C. Hicks, a Member in the Corporate & Securities Section of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., will be the moderator of a panel discussion at the 15th annual BIO CEO & Investor Conference. The conference is being held February 12-15 in New York.

“The Road Less Traveled: Alternative Avenues to Public Markets.”

Mr. Hicks will be moderating a discussion entitled, “The Road Less Traveled: Alternative Avenues to Public Markets.” The discussion will focus on the increasing number of companies that have employed alternate routes to the public markets, using reverse mergers, Form-10 self-filings, and variations of each to avoid the expense, uncertainty and complexity of the IPO process. The panelists include:

  • Charles Crain, Manager, Policy & Research, BIO
  • Michelle Dipp, MD, PhD, Chief Executive Officer & Co-Founder, OvaScience
  • Daniel B. Dubin, MD, Vice Chairman, Chief Knowledge Officer & Founder of MEDACorp, Leerink Swann
  • Peter Kolchinsky, PhD, Managing Partner, RA Capital

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies.

For more information about Mintz Levin, please visit www.mintz.com.

Contacts

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Gina Addis, 617-348-4413
GADDIS@MINTZ.COM

Recent Stories

RSS feed for Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Release Summary

William C. Hicks, a Member in the Corporate & Securities Section of Mintz Levin, will be the moderator of a panel discussion at the 15th annual BIO CEO & Investor Conference.

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.